Atorvastatin in New Onset Type 1 Diabetes Mellitus (T1DM)

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2013

Conditions
Type 1 Diabetes
Interventions
DRUG

Atorvastatin

Pill, initially at 10 mg, then after 4 weeks, 20 mg Once daily for a total of 12 months

OTHER

Placebo

One out of three subjects will receive a placebo.

Trial Locations (1)

19104

Diabetes Center for Children & Clinical Translational Research Center, Philadelphia

All Listed Sponsors
collaborator

FDA Office of Orphan Products Development

FED

collaborator

Medical University of South Carolina

OTHER

lead

Children's Hospital of Philadelphia

OTHER

NCT00529191 - Atorvastatin in New Onset Type 1 Diabetes Mellitus (T1DM) | Biotech Hunter | Biotech Hunter